IDEAS home Printed from https://ideas.repec.org/a/eee/tefoso/v80y2013i5p932-943.html
   My bibliography  Save this article

On the assignment of biopharmaceutical patents

Author

Listed:
  • Madeira, L.S.
  • Borschiver, S.
  • Pereira, N.

Abstract

This study focuses on the patent assignments for six selected biopharmaceuticals: filgrastim, infliximab, somatropin, imiglucerase, betainterferon and factor VIII. These very expensive proteins are not currently produced in Brazil, and their production would enhance Brazilian technological capacity. Accordingly, we characterized the current profiles of the patent holders for these proteins. Data mining techniques were used to simplify the screening and analysis of thousands of patent entries retrieved from data banks worldwide, using the International Patent Classification (IPC) codes A61K, A61P and C12N as a guide. A critical assessment of the historical evolution of biopharmaceutical patents and a geographic distribution analysis of their depositors conclude that individual depositors have a strong, growing influence on the overall patent assignment profile. Individual depositors file patents primarily in collaboration with companies, research centers or universities. We also concluded that, in the next few years, emerging or spin-offs companies will constitute an increasing share of the competitors of consolidated technology holders (Big Pharma companies, research centers and universities). This information may prove interesting for entrepreneurs involved in public, private or joint ventures regarding the fabrication of strategic biopharmaceuticals.

Suggested Citation

  • Madeira, L.S. & Borschiver, S. & Pereira, N., 2013. "On the assignment of biopharmaceutical patents," Technological Forecasting and Social Change, Elsevier, vol. 80(5), pages 932-943.
    • Handle: RePEc:eee:tefoso:v:80:y:2013:i:5:p:932-943
    DOI: 10.1016/j.techfore.2012.10.016
    as

    Download full text from publisher

    File URL: http://www.sciencedirect.com/science/article/pii/S0040162512002624
    Download Restriction: Full text for ScienceDirect subscribers only
    File URL: https://libkey.io/10.1016/j.techfore.2012.10.016?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Coccia, Mario & Wang, Lili, 2015. "Path-breaking directions of nanotechnology-based chemotherapy and molecular cancer therapy," Technological Forecasting and Social Change, Elsevier, vol. 94(C), pages 155-169.
    2. Santiago, Leonardo P. & Martinelli, Marcela & Eloi-Santos, Daniel T. & Hortac, Luciana Hashiba, 2015. "A framework for assessing a portfolio of technologies for licensing out," Technological Forecasting and Social Change, Elsevier, vol. 99(C), pages 242-251.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:eee:tefoso:v:80:y:2013:i:5:p:932-943. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Catherine Liu (email available below). General contact details of provider: http://www.sciencedirect.com/science/journal/00401625 .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.